HIV and Hepatitis C Among People Who Inject Drugs in Memphis, Tennessee: an Intersectional Risk Environment Analysis of the Social Determinants of Health

被引:0
|
作者
Flath, Natalie [1 ]
Marr, Jack H. [2 ]
Sizemore, Lindsey [3 ]
Pichon, Latrice C. [4 ]
Brantley, Meredith [5 ]
机构
[1] Johns Hopkins Bloomberg, Sch Publ Hlth, Dept Mental Hlth, 624 N Broadway, Baltimore, MD 21205 USA
[2] Tennessee Dept Hlth, Communicable & Environm Dis & Emergency Preparedn, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[3] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
[4] Univ Memphis, Sch Publ Hlth, Div Social & Behav Sci, 209 Robison Hall, Memphis, TN 38152 USA
[5] Tennessee Dept Hlth, 710 James Robertson Pkwy,4th Floor, Nashville, TN 37243 USA
关键词
HIV; HCV; Persons who inject drugs; Social determinants of health; Intersectional public health; OPIOID CRISIS; UNITED-STATES; B-VIRUS; BALTIMORE; INFECTION; VULNERABILITY; POPULATIONS; DISPARITIES; IMPACT; AIDS;
D O I
10.1007/s40615-023-01878-x
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundThe Southern US is confronting bourgeoning HIV and hepatitis C virus (HCV) epidemics among people who inject drugs (PWID), yet little is known about shared and unique risk factors across the region. We applied an intersectional risk environment framework to understand infectious disease outcomes for sub-groups of PWID that experience multiple axes of social marginalization related to racial and ethnic identity and social and economic vulnerability.MethodsHIV and HCV prevalence was estimated from the first iteration of the CDC's National HIV Behavioral Surveillance respondent driven sample of PWID in Shelby County, Tennessee in 2018. We ran adjusted multinomial models to test main and interaction effects of race/ethnicity and structural factors on the prevalence of a three-level outcome: HIV-only, HCV-only, and no infection.ResultsA total of 564 PWID participated, 558 (99%) completed HIV testing, and 540 (96%) HCV testing. Thirty (5%) were HIV-positive, 224 (40%) HCV-positive, and less than 1% were co-infected. Descriptive differences by race/ethnicity and levels of structural vulnerability for HIV and HCV subpopulations were present; however, there was no evidence for statistical interaction. In the final main effects model, HIV status was positively associated with non-Hispanic Black identity (aRR 4.95, 95% CI 1.19, 20.6), whereas HCV status was associated with non-white identity (aRR 0.11 95% CI 0.07, 0.18). Factors associated with HCV infection were higher scores of structural vulnerability (aRR 2.19 95% CI 1.10, 4.35), and criminal legal involvement (aOR 1.99 95% CI 1.18, 3.37).ConclusionThis is the first study to implement local population-based survey data to evaluate distinctive intersections of ethnic/racial and social factors associated with HIV and HCV status among PWID in the Memphis region. Findings come at an opportune time as harm reduction programs are in development in the South and shed light to the need for socially equitable race conscious resource investment.
引用
收藏
页码:361 / 373
页数:13
相关论文
共 50 条
  • [21] Incarceration history and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis
    Stone, Jack
    Fraser, Hannah
    Lim, Aaron G.
    Walker, Josephine G.
    Ward, Zoe
    MacGregor, Louis
    Trickey, Adam
    Abbott, Sam
    Strathdee, Steffanie A.
    Abramovitz, Daniela
    Maher, Lisa
    Iversen, Jenny
    Bruneau, Julie
    Zang, Geng
    Garfein, Richard S.
    Yen, Yung-Fen
    Azim, Tasnim
    Mehta, Shruti H.
    Milloy, Michael-John
    Hellard, Margaret E.
    Sacks-Davis, Rachel
    Dietze, Paul M.
    Aitken, Campbell
    Aladashvili, Malvina
    Tsertsvadze, Tengiz
    Mravcik, Viktor
    Alary, Michel
    Roy, Elise
    Smyrnov, Pavlo
    Sazonova, Yana
    Young, April M.
    Havens, Jennifer R.
    Hope, Vivian D.
    Desai, Monica
    Heinsbroek, Ellen
    Hutchinson, Sharon J.
    Palmateer, Norah E.
    McAuley, Andrew
    Platt, Lucy
    Martin, Natasha K.
    Altice, Frederick L.
    Hickman, Matthew
    Vickerman, Peter
    LANCET INFECTIOUS DISEASES, 2018, 18 (12): : 1397 - 1409
  • [22] HIV and Hepatitis C Prevalence and Risk Behavior among People Who Inject or Inhale Drugs in Whitehorse, Yukon, Canada.
    Machalek, K.
    Hanley, B. E.
    Bacon, P.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2015, 44 : 58 - 58
  • [23] Assessing risk of HIV and hepatitis C among people who inject drugs in East Africa: Findings from a rapid assessment
    Platt, Lucy
    Stengel, Camille May
    Nkurunziza, Menus
    Muhangi, Denis
    Byansi, Peter
    Wandiembe, Peter
    Busago, Andre
    Bitira, David
    Mundia, Bernard
    Onesmus, Mlewa
    Rhodes, Tim
    JOURNAL OF VIRAL HEPATITIS, 2019, 26 (07) : 926 - 929
  • [24] Risk factors associated with HIV and hepatitis C virus co-infection among people who inject drugs in Cambodia
    Saing, Chan Hang
    Prem, Kiesha
    Uk, Ponha
    Chhoun, Pheak
    Chann, Navy
    Tuot, Sovannary
    Mun, Phalkun
    Yi, Siyan
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2020, 86
  • [25] Hepatitis C Treatment in People Who Inject Drugs
    Benjamin Eckhardt
    Current Treatment Options in Infectious Diseases, 2016, 8 (4) : 416 - 425
  • [26] Hepatitis C infection in people who inject drugs
    Azim, T.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2016, 45 : 41 - 42
  • [27] Reasons for Not Seeking Hepatitis C Treatment among People Who Inject Drugs
    Morris, Leith
    Selvey, Linda
    Williams, Owain
    Gilks, Charles
    Smirnov, Andrew
    SUBSTANCE USE & MISUSE, 2020, 56 (02) : 175 - 184
  • [28] SYMPOSIUM: ENHANCING HEPATITIS C CARE AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    Marshall, Alison D.
    Grebely, Jason
    Dore, Gregory J.
    Treloar, Carla
    Corry, Angela
    Hayllar, Jeremy
    Byrne, Jude
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S8 - S9
  • [29] HEPATITIS C TREATMENT, REINFECTION AND ELIMINATION AMONG PEOPLE WHO INJECT DRUGS
    Hajarizadeh, Behzad
    DRUG AND ALCOHOL REVIEW, 2019, 38 : S9 - S9
  • [30] Dynamic modeling of hepatitis C transmission among people who inject drugs
    Stocks, Theresa
    Martin, Leah J.
    Kuhlmann-Berenzon, Sharon
    Britton, Tom
    EPIDEMICS, 2020, 30